Rashi Mehta
Kourtney Kardashian is facing significant backlash following the launch of her new weight loss supplement, Lemme GLP-1 Daily, which is marketed as an “all-natural” alternative to Ozempic. The product, which aims to mimic the effects of the popular prescription medication used for weight loss and diabetes management, has sparked controversy online.
The controversial weight loss product
Following her announcement about the release of a new weight loss product through her health brand Lemme, Kourtney Kardashian has received a lot of negative feedback online. Lemme GLP-1 Daily is a gummy that is said to aid in weight loss by “naturally increasing the body’s GLP-1 production, a hormone involved in regulating appetite and metabolic health.” However, the 45-year-old reality TV celebrity is receiving backlash online for this product.
Social media users have criticized Kardashian for promoting a product that they believe lacks sufficient scientific backing. Comments on her Instagram announcement included skepticism about the effectiveness of the supplement and concerns over its safety, with some users suggesting it could lead to legal issues due to potential misleading claims. Critics pointed out that while the supplement is designed to boost the body’s GLP-1 hormone levels—important for appetite regulation—it does not contain synthetic GLP-1 and is not a GLP-1 receptor agonist like Ozempic.
Kourtney defends her product
In response to the backlash, Kardashian defended her product, stating that it was developed in collaboration with a medical advisory board and includes clinically studied ingredients such as Eriomin Lemon Fruit Extract, Supresa Saffron Extract, and Morosil Red Orange Fruit Extract. She emphasized that Lemme GLP-1 Daily was formulated to provide a natural solution for those seeking alternatives to prescription medications.
Despite Kardashian’s assurances, experts have expressed doubts about the supplement’s efficacy compared to traditional GLP-1 medications. Nutritionists have highlighted that no over-the-counter supplement can replicate the effects of prescription drugs like Ozempic, which are known for their significant impact on weight loss and metabolic health.
Lemme GLP-1 Daily is set to launch on September 16, 2024, priced at $72 for a subscription or $90 for a one-time purchase.
GIPHY App Key not set. Please check settings